These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 5030580)

  • 1. Alteration of the specificity of antitumor antisera by the use of passively administered antibody.
    Ungaro PC; Drake WP; Buchholz DH; Mardiney MR
    Cancer Res; 1972 Jul; 32(7):1521-5. PubMed ID: 5030580
    [No Abstract]   [Full Text] [Related]  

  • 2. Mammary tumor virus-associated antigenicity of L-1210 murine leukemia cells.
    Kisielow P; Radzikowski C; Steuden J; Szkudlarek J; Krawczynski K
    Arch Immunol Ther Exp (Warsz); 1971; 19(6):789-99. PubMed ID: 4335186
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of immune factors on the motility of lymphoma cells.
    Cochran AJ; Klein E; Keissling R
    J Natl Cancer Inst; 1972 Jun; 48(6):1657-61. PubMed ID: 4560294
    [No Abstract]   [Full Text] [Related]  

  • 4. Preparation of monospecific HLA antibodies from cross-reactive multispecific antisera.
    Cross DE; Whittier FC; Greiner RF; Foxworth J; Weaver P; Ross JA
    Tissue Antigens; 1976 Aug; 8(2):101-8. PubMed ID: 968895
    [No Abstract]   [Full Text] [Related]  

  • 5. Proportional absorption. A method for determination of the relative specificity of antisera prepared against cells.
    Reif AE; Robinson CM
    Immunology; 1975 Jan; 28(1):199-205. PubMed ID: 1090519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Passive enhancement of mouse skin allografts. Specificity of the antiserum for major histocompatibility.
    Staines NA; Guy K; Davies DA
    Transplantation; 1974 Aug; 18(2):192-5. PubMed ID: 4602953
    [No Abstract]   [Full Text] [Related]  

  • 7. Cross-reactivity between HL-A and H-2 antigens. II. Allogeneic sensitization by xenogeneic soluble lymphocyte antigens (HL-A).
    Götze BD; Lee S; Ferrone S; Pellegrino MA; Reisfeld RA
    Transplant Proc; 1973 Mar; 5(1):467-70. PubMed ID: 4572106
    [No Abstract]   [Full Text] [Related]  

  • 8. Cytotoxic immune cells with specificity for defined soluble antigens. V. Interaction of antibody with the cytotoxic effector cells in immune or non-immune mouse spleen cells.
    Schirrmacher V; Rubin B; Pross H
    J Immunol; 1974 Jun; 112(6):2219-26. PubMed ID: 4856907
    [No Abstract]   [Full Text] [Related]  

  • 9. Human leukemia antigen. I. Production and characterization of antisera.
    Billing R; Terasaki PI
    J Natl Cancer Inst; 1974 Dec; 53(6):1635-8. PubMed ID: 4612163
    [No Abstract]   [Full Text] [Related]  

  • 10. Cross-reactions of mouse anti-H-2 sera with human HL-A antigens.
    Ivasková E; Macurová H; Bavorová H; Micková M; Iványi P
    Haematologia (Budap); 1974; 8(1-4):273-9. PubMed ID: 4461424
    [No Abstract]   [Full Text] [Related]  

  • 11. Serologic homology between H-2 and HL-A system.
    David CS; Klein J; Shreffler DC
    Transplant Proc; 1973 Mar; 5(1):461-6. PubMed ID: 4633089
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytotoxic effect of anti-H-2 sera on human lymphocytes: association with HL-A7 and W27.
    Ivasková E; Iványi P
    Folia Biol (Praha); 1974; 20(4):283-5. PubMed ID: 4412697
    [No Abstract]   [Full Text] [Related]  

  • 13. Synergistic cooperation between isoantiserum and immune lymphoid cells: in vitro studies with a syngeneic rat lymphoma.
    Ortiz de Landazuri M; Kedar E; Fahey JL
    J Immunol; 1974 Jun; 112(6):2102-10. PubMed ID: 4825787
    [No Abstract]   [Full Text] [Related]  

  • 14. T and B lymphocytes in mice studied by using antisera against surface antigenic markers.
    Raff MC
    Am J Pathol; 1971 Nov; 65(2):467-78. PubMed ID: 4944155
    [No Abstract]   [Full Text] [Related]  

  • 15. Formalin-fixed cell preparations as standards for use in the automated trypan blue cytotoxic assay.
    Drake WP; Ungaro PC; Mardiney MR
    Transplantation; 1972 Jul; 14(1):127-30. PubMed ID: 4113841
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibody against neoplastic plasma cells. I. Specific surface antigens on mouse myeloma cells.
    Watanabe T; Yagi Y; Pressman D
    J Immunol; 1971 May; 106(5):1213-21. PubMed ID: 5574404
    [No Abstract]   [Full Text] [Related]  

  • 17. The application of an in vitro cytotoxicity test to studies of the effects of drugs on the cellular immune response in mice. I. Primary response.
    Fass L; Fefer A
    J Immunol; 1972 Oct; 109(4):749-53. PubMed ID: 5074330
    [No Abstract]   [Full Text] [Related]  

  • 18. Immune stimulation-inhibition of experimental cancer metastasis.
    Fidler IJ
    Cancer Res; 1974 Mar; 34(3):491-8. PubMed ID: 4812256
    [No Abstract]   [Full Text] [Related]  

  • 19. Association of tumor and histocompatibility antigens in sera of lymphoma-bearing mice.
    Fujimoto S; Chen CH; Sabbadini E; Sehon AH
    J Immunol; 1973 Oct; 111(4):1093-100. PubMed ID: 4728678
    [No Abstract]   [Full Text] [Related]  

  • 20. Cellular formation of viriolytic antibody by mouse immunocytes: cytokinetics and specificity.
    McAlack RF; Cerny J; Friedman H
    J Immunol; 1971 Dec; 107(6):1752-65. PubMed ID: 4941115
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.